These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 9465532

  • 1. Resistance to quinolones in pathogens causing urinary tract infections.
    Kapoor H, Aggarwal P.
    J Commun Dis; 1997 Sep; 29(3):263-7. PubMed ID: 9465532
    [Abstract] [Full Text] [Related]

  • 2. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
    Yüksel S, Oztürk B, Kavaz A, Ozçakar ZB, Acar B, Güriz H, Aysev D, Ekim M, Yalçinkaya F.
    Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
    [Abstract] [Full Text] [Related]

  • 3. Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients.
    Tayfour M, Yuce A, Yulug N.
    Saudi Med J; 2001 Oct; 22(10):848-51. PubMed ID: 11744939
    [Abstract] [Full Text] [Related]

  • 4. A high incidence of ciprofloxacin resistance in urinary isolates in eastern Nepal.
    Srinivasa H, Parija SC, Bhattacharya S, Sehgal R.
    J Commun Dis; 1999 Mar; 31(1):45-7. PubMed ID: 10810586
    [Abstract] [Full Text] [Related]

  • 5. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua.
    Matute AJ, Hak E, Schurink CA, McArthur A, Alonso E, Paniagua M, Van Asbeck E, Roskott AM, Froeling F, Rozenberg-Arska M, Hoepelman IM.
    Int J Antimicrob Agents; 2004 May; 23(5):506-9. PubMed ID: 15120732
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Piccolomini R, Cellini L, Allocati N, Di Girolamo A, Selan L, Scazzocchio F.
    Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The frequency of in vitro resistance to fluoroquinolones among clinical isolates of Escherichia coli.
    Poiată A, Bădicuţ I, Grigore L, Buiuc D.
    Roum Arch Microbiol Immunol; 2000 Oct; 59(1-2):63-9. PubMed ID: 11845477
    [Abstract] [Full Text] [Related]

  • 11. [The in vitro activity of ofloxacin, pefloxacin and ciprofloxacin against various gram negative bacteria isolated from urinary tract infections].
    Tunçkanat F, Yuluğ N.
    Mikrobiyol Bul; 1988 Oct; 22(3):187-92. PubMed ID: 3252111
    [Abstract] [Full Text] [Related]

  • 12. [Trends and changes in antimicrobial resistance of clinical isolates from 11 hospitals in Beijing area].
    Zhang F, Jin S, Wu Q.
    Zhonghua Yi Xue Za Zhi; 1997 May; 77(5):327-31. PubMed ID: 9772484
    [Abstract] [Full Text] [Related]

  • 13. Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.
    Brothers AM, Gibbs PS, Wooley RE.
    Vet Ther; 2002 May; 3(4):493-500. PubMed ID: 12584687
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and antimicrobial susceptibility of Escherichia coli in outpatient urinary isolates in Izmir, Turkey.
    Yilmaz N, Agus N, Yurtsever SG, Pullukcu H, Gulay Z, Coskuner A, Kose S, Aydemir S, Gulenc N, Ozgenc O.
    Med Sci Monit; 2009 Nov; 15(11):PI61-5. PubMed ID: 19865064
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA, Thornsberry C, Jones ME, Sahm DF.
    Clin Infect Dis; 2003 Jan 15; 36(2):183-7. PubMed ID: 12522750
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H, Azap OK, Ergönül O, Timurkaynak F, Urinary Tract Infection Study Group.
    J Antimicrob Chemother; 2005 Nov 15; 56(5):914-8. PubMed ID: 16174685
    [Abstract] [Full Text] [Related]

  • 17. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data.
    Alós JI, Serrano MG, Gómez-Garcés JL, Perianes J.
    Clin Microbiol Infect; 2005 Mar 15; 11(3):199-203. PubMed ID: 15715717
    [Abstract] [Full Text] [Related]

  • 18. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R, Allocati N, Catamo G.
    Chemioterapia; 1984 Jun 15; 3(3):167-72. PubMed ID: 6241505
    [Abstract] [Full Text] [Related]

  • 19. [Antimicrobial resistance of agents causing urinary tract infections in 11 Chilean hospitals. PRONARES project].
    Valdivieso F, Trucco O, Prado V, Díaz MC, Ojeda A.
    Rev Med Chil; 1999 Sep 15; 127(9):1033-40. PubMed ID: 10752265
    [Abstract] [Full Text] [Related]

  • 20. [Profile of antimicrobial resistance of agents causing urinary tract infections in Chilean children. PRONARES surveillance program].
    Prado V, Trucco O, Durán C, Mamani R, Royer M, Programa Nacional de Vigilancia de Resistencia (PRONARES).
    Rev Med Chil; 2001 Aug 15; 129(8):877-85. PubMed ID: 11680961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.